EchoX focuses on developing medical imaging analysis software together with large-scale data analysis platforms for automatic processing of ultrasound images. Most healthcare companies provide ultrasound imaging system solutions, which focus on significant technological development in echocardiography and breast ultrasound. Unlike the hot research of echocardiography and breast ultrasound, the research of ultrasound applied in other organs and soft tissues of the body, like lung, vein, and bladder is still limited, but has a promising future. As a result, currently existing commercial ultrasound solutions are more limited. EchoX will commit to fill the gap caused by limited ultrasound imaging system solutions, which are served in other organs and soft tissues. EchoX will initially focus on the development of intelligent ultrasound products in lung and vessel ultrasound, and gradually develop other new products to expand our business. EchoX is a Hong Kong-based start-up which aims to ma...
EchoX focuses on developing medical imaging analysis software together with large-scale data analysis platforms for automatic processing of ultrasound images. Most healthcare companies provide ultrasound imaging system solutions, which focus on significant technological development in echocardiography and breast ultrasound. Unlike the hot research of echocardiography and breast ultrasound, the research of ultrasound applied in other organs and soft tissues of the body, like lung, vein, and bladder is still limited, but has a promising future. As a result, currently existing commercial ultrasound solutions are more limited. EchoX will commit to fill the gap caused by limited ultrasound imaging system solutions, which are served in other organs and soft tissues. EchoX will initially focus on the development of intelligent ultrasound products in lung and vessel ultrasound, and gradually develop other new products to expand our business. EchoX is a Hong Kong-based start-up which aims to make ultrasound imaging an accessible and ubiquitous tool in medicine and use ultrasound imaging to solve common and everyday problems in healthcare. This will be achieved through collaborating with a wide range of hospitals and clinical institutes with clinical evaluation and verification. Our goal is to become a leading artificial intelligence (AI) station platform for ultrasound imaging analysis, using a targeted roll-out in Hong Kong and Mainland as a springboard for international expansion.
Our first product called EchoEffusion is an automatic pleural effusion detection software based on state-of-the-art AI technology. Given an exclusive partnership with Division of Respiratory Medicine at Queen Mary Hospital and an approved human ethics study protocol, the product will be clinically tested and verified in Division of Respiratory Medicine at Queen Mary Hospital in the future. Another product prototype is an ultrasound-based computer-aided tool for peripheral intravenous (IV) placement, which is used to detect vein and artery automatically, and provide AI-assisted high-quality ultrasound vein images. EchoX will provide services in ultrasound imaging analysis and processing through AI technology as the catalyst for the widespread use of ultrasound imaging, particularly in rural regions and homecare.
More information

Employees

Xiaofei Sun
Admin
Xiaofei Sun CEO MPhil in Medical Imaging from CUHK.